Previous Close | 0.0700 |
Open | 0.0675 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.0675 - 0.0779 |
52 Week Range | 0.0630 - 0.1600 |
Volume | |
Avg. Volume | 40,870 |
Market Cap | 10.583M |
Beta (5Y Monthly) | 0.54 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform with one of the strongest portfolios of brands in key strategic U.S. markets, will report its financial results for the three months and nine-month transition period ended December 31, 2023, after markets close on Monday, April 29, 2024. As previously announced, due to a change in the Company's fiscal year end from March 31st to Dece
RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform with one of the strongest portfolios of cannabis brands in key strategic U.S. markets, today announced that Etain will open its first co-located adult-use and medical dispensary in White Plains, New York.
RIV Capital Inc. ("RIV Capital") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform with one of the strongest portfolios of cannabis brands in key strategic U.S. markets, today announced that the New York Cannabis Control Board (the "CCB") approved Etain, LLC's (the "Company") transition to an adult-use operator with cultivation, processing, distribution, and retail operations.